Featured Articles

Features

In today’s pharmaceutical landscape, speed, compliance, and efficiency are no longer optional—they’re strategic imperatives. Yet for large capital expenditure (CapEx) projects, traditional paper-based commissioning, qualification, and validation (CQV) workflows remain a major bottleneck, consuming time, resources, and patience.

Features
The pharmaceutical industry is at a pivotal moment. The pressure to deliver safe, high-quality medicines to patients faster has never been greater, and the systems used to ensure compliance must evolve to meet that challenge. Commissioning and qualification (C&Q), long the bedrock of pharmaceutical engineering and compliance are being reshaped by new science- and risk-based approaches that...
Features

Radiopharmaceuticals account for many lifesaving diagnostic and therapeutic drug products in the market. These drug products, radioligand therapies (RLTs) in particular, represent a relatively novel modality and present multiple, unique challenges to manufacture, release, ship, and administer.

Features

ASTM E2500, issued in 2007, has been the primary standard guide defining what is required to apply quality risk management (QRM) to achieve the qualification of facilities, systems, and equipment in support of validation and process validation. A major update was undertaken in 2024 to better align the guide with current regulatory and industry guidance and current best practice.

Features

Schedule management faces challenges such as unrealistic deadlines, scope creep, resource constraints, and poor communication, often causing delays and cost overruns. Using tools like an interdependency matrix (IDM) with project management software tools like Microsoft Project improves accuracy, visibility, and control.

Features

This article provides guidance on the best practices to adopt when preparing for an audit or inspection, with a particular focus on commissioning and qualification and the points to consider during the development of materials to explain a company’s individual approach to commissioning, qualification, and validation maintenance.

Technical

Since the US Food and Drug Administration (FDA) introduced the requirement for secure, computer-generated, time-stamped audit trails in 21 CFR Part 11, audit trail functionality has been recognized as a critical component of data integrity.

Technical

The COVID-19 pandemic revealed how unprepared the vaccine industry was for such a global health emergency, but also how the industry rose to meet this challenge. The first efficient COVID-19 vaccines approved were based on a new class of vaccines using messenger ribonucleic acid (mRNA) technology.

Technical

As facilities become more complex and equipment requirements more demanding, engineers face increasing challenges in ensuring optimal airflow patterns. Fortunately, advanced digital tools such as computational fluid dynamics (CFD) and building information modeling (BIM) are revolutionizing the way cleanrooms are engineered.

Technical

Qualification of equipment used in the manufacturing of pharmaceutical products is a critical step in ensuring the production of a product that consistently meets all critical quality attributes. The US Food and Drug Administration (FDA) has stated a shelf temperature mapping, or a shelf temperature uniformity study is an expected step in the qualification of lyophilizers (freeze dryers).

InTouch

Chip Bennett, Senior Director at Project Farma, is a Project Management Institute®–certified Project Management Professional (PMP), recognized industry expert, speaker, and published author. He is a consultant with more than 25 years of experience in the pharmaceutical and regulated non-pharmaceutical industries and has expertise in risk-based commissioning and qualification...

InTouch

Stephanie White is a pharmaceutical and biotechnology manufacturing leader with more than 23 years of experience helping teams turn high-stakes projects into confident, inspection-ready operations. She now serves as a Commissioning, Qualification, and Validation (CQV) and Operational Readiness Lead at A-Bio, a consulting firm, supporting sterile manufacturing and complex capital programs. Her...

Features
Computerized system validation (CSV) remains a cornerstone of regulatory compliance, but it is still time-consuming, resource-intensive, and prone to human error. Risk assessments, test development, traceability, and documentation absorb enormous effort and often slow down innovation. Artificial intelligence (AI) has the potential to change this.
Features

Categorization offers a useful starting point for assessing the risk of failure for individual software components, but it is not a validation checklist. Organizations must apply critical thinking to combine categorization with risk assessment and supplier assessments to appropriately scale life cycle activities and manage risk.

Features
Large language models (LLMs) can enable decision support in pharmaceutical manufacturing but can also create risks through overreliance. LLM-enabled computerized systems have the potential to increase assessment consistency and performance in a scalable way for automated decision-making workflows.
Features

This article presents a model for promoting data quality of real-world data and evidence (RWD/RWE) and GxP processes with references to ISO 8000 for data quality management, making it a common language between regulated and nonregulated organizations.

Features

Data integrity drives quality and compliance. Content addressable storage (CAS) stores and retrieves files by content type—not file location—using cryptographic fingerprints. The result: a mathematically provable version control, without broken links and far fewer audit headaches.

Features
Clinical trial sponsors who delegate responsibilities to service providers supporting anything from a small, single-site Phase I study to a global Phase III program are now operating under a fully revised ICH GCP E6(R3).
Features
Pharmaceuticals are not only regulated by traditional pharmaceutical legislation but are also increasingly influenced by related environmental and stewardship laws. Extended producer responsibility (EPR) is reshaping the pharmaceutical industry with regulatory burdens, challenges, and strategic opportunities.
Features

Sustainability principles can be effectively integrated into commissioning and qualification (C&Q) projects to support environmental goals without compromising compliance, quality, or patient safety. By positioning C&Q as both a verification tool and an enabler of sustainable intent, this article outlines a practical path for the pharmaceutical sector to enhance operational efficiency,...

Features

The development of platform drug delivery devices for combination products offers a transformative approach to drug delivery by enabling the reuse of device data across multiple drug and device combinations.

Explore

White Paper
This whitepaper provides principles and practical expectations for manufacturing operations within the scope of GMP Annex 1, focusing on four areas: environmental monitoring and control; aseptic process validation; equipment and facility design; and personnel practices. Each subject area was drafted as an individual chapter to the whitepaper by multicompany and multidisciplinary teams with...
White Paper
The life science validation sector is evolving with a focus on risk-based methodologies and increased access to digital data, driving innovation. The rise of Digital Validation Tools (DVTs) reflects the industry's emphasis on data integrity and principles of Pharma 4.0 and Validation 4.0. These advancements streamline monitoring and provide real-time insights into validated statuses through...
White Paper

Currently, there is no single guidance document providing a comprehensive roadmap for executing digital validation. While elements from ISPE GAMP® Guides Series and the ISPE Baseline® Guide: Volume 8 – Pharma 4.0™, apply to digital validation, there is no consolidated resource addressing common questions. The authors of this Concept Paper therefore advocate for the development of a Good...

Latest Articles

iSpeak Blog

The ISPE Mid-Atlantic Science and Technology Showcase (MAST) in Baltimore, Maryland, USA held on 7 May highlighted the strength, technical capability, and collaborative spirit of the life sciences industry. Hosted by the ISPE Chesapeake Bay Area Chapter at M&T Bank Stadium, the show brought together more than 950 registrants from across the pharmaceutical and biotechnology community for a...

iSpeak Blog

As a fitting conclusion to the 2026 ISPE Europe Annual Conference, 30 conference attendees took the opportunity to step inside one of the industry’s most advanced biologics manufacturing facilities during a sold out tour of the FUJIFILM Biotechnologies site in Hillerød, Denmark. Held on Thursday, 23 April, the sold-out tour offered attendees an in depth look at how large scale biologics...

iSpeak Blog

The current upstream process, particularly the synthesis step, that has been widely used in the industry, is the Solid Phase Oligonucleotide Synthesis (SPOS). While SPOS remains functional for many companies, it is increasingly perceived as being at the brink of capacity limits, especially in light of the projected increases in demand.

iSpeak Blog
Everyone can agree patients need reliable access to their medicines. When a cancer patient can't get their chemotherapy, when a parent can't find their child's seizure medication, when a hospital runs low on a critical anesthetic, these aren't abstract policy problems. They're human crises. As a result, preventing shortages has been a shared priority for many stakeholders, including the US...
iSpeak Blog

The life sciences industry is undergoing a profound digital transformation, driven by the convergence of artificial intelligence (AI), cloud computing, and advanced analytics. These technologies are reshaping how organizations manage quality across the product lifecycle from development and manufacturing to post-market surveillance.

iSpeak Blog
Out of more than 150 applicants in the program's first year, nine emerging pharmaceutical professionals were selected to receive the inaugural Jack Lysfjord Grant, which supported 2026 ISPE Aseptic Conference attendance. They arrived in Washington, D.C., USA as students and early career professionals. They left as something more—connected, challenged, and with a clearer sense of where they fit in...
iSpeak Blog
Computerized systems are at the heart of modern pharmaceutical and biopharmaceutical operations. From development and manufacturing to quality systems and supply chain management, digital technologies enable efficiency, traceability, and innovation. But with this reliance comes regulatory expectations and requirements and the need for professionals who understand how to manage and validate these...
iSpeak Blog
In biopharmaceutical manufacturing, SPC charts and Nelson Rules are foundational tools for monitoring process performance. Among them, Nelson Rule 2 is widely used to detect potential shifts in process behavior. However, while statistically sound, the rule is often misleading in practice. It evaluates only the direction of data and number of data relative to the mean and ignores the magnitude of...
iSpeak Blog
Yanet Flor’s professional journey reflects the global impact and career-shaping potential of active engagement with ISPE. She joined ISPE approximately four years ago while completing her pharmacy studies and beginning her career in pharmaceutical manufacturing. At that early stage, Yanet frequently relied on ISPE guidelines to navigate technical and regulatory questions, using them as trusted...
iSpeak Blog
The draft of EU GMP Annex 22 issued in late 2025 reads: “The document applies to models with a deterministic output which, when given identical inputs, provide identical outputs. Models with a probabilistic output which, when given identical inputs, might not provide identical outputs are not covered by this document and should not be used in critical GMP applications.”
iSpeak Blog

Careers in pharmaceutical and biopharmaceutical manufacturing are rarely linear. They evolve across technical disciplines, leadership roles, and life stages—and the professionals who thrive are often those with a steady anchor. For Lindsey Daniel, PE, Head of Global Operational Excellence, Biologics, at Takeda, that anchor has been ISPE.

iSpeak Blog

The pharmaceutical industry is undergoing one of the most intense periods of transformation in its history. Advances in science, the acceleration of digital technologies, evolving regulatory expectations, and mounting sustainability pressures are reshaping how medicines are developed and manufactured. Against this backdrop, the

iSpeak Blog
The first installment of this series walked through the development of electrical classifications in biotech manufacturing facilities and briefly discussed open and closed facilities in that context. This installment takes a closer look at open and closed facilities, and their characteristics.
iSpeak Blog

The life sciences and diagnostics industry are undergoing a transformative digital evolution. Laboratory systems, electronic lab notebooks (ELN), TrackWise Digital (TWD), and enterprise content management platforms like Livelink are increasingly integrated with clinical, quality, and operational workflows. These technologies improve efficiency, traceability, and operational scalability, but...

iSpeak Blog

The GAMP® South Asia Community of Practice (CoP) convened on 5 February 2026 to explore one of the most important topics facing the life sciences today: how to build and use trustworthy AI, kindly hosted by the ISPE Philippines Affiliate. This virtual event brought together professionals across the region—many already experimenting with AI, others just beginning their journey—for an...

Current Issue

March / April 2026

As technological advances sweep the pharmaceutical industry, this issue explores C&Q digitalization to ensure alignment with current practices.